PREDICTORS OF A LOCAL RECURRENCE AFTER ORGAN-PRESERVING TREATMENT FOR EARLY BREAST CANCER: STATE-OF-THE-ART
https://doi.org/10.17650/1994-4098-2009-0-1-2-16-20
Abstract
There are currently many unsolved problems associated with the optimization of treatment in patients with breast cancer (BC) who have undergone organ-preserving operations. The occurrence of BC recurrences after organ-preserving treatment, their determination and prognostic factors are a challenge.
About the Authors
N. R. Molodikova
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
M. I. Nechushkin
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
V. A. Uimanov
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
A. V. Trigolosov
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
M. V. Chernykh
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
N. V. Bekuzarova
N.N. Blokhin Russian Cancer Research Center, Moscow
Russian Federation
Russian Federation
References
1. Хмелевский Е.В. Лучевая терапия рецидивов рака молочной железы. Вопр онкол 2000;46(2):167.
2. Семиглазов В.Ф., Нургазиев К.Ш., Арзуманов А.С. Опухоли молочной железы (лечение и профилактика). Алматы, 2001.
3. Voogd A.C., van Oost F.J., Rutgers E.J.T. et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 2005;41(17):2637—44.
4. De La Rochefordiere A., Asselain B., Campana F. Age as a prognostic factor in premenopausal breast carcinoma. Lancet 1993;(341):1039—43.
5. Clemente C.G., Boracchi P., Del Vecchio M. Peritumoral lymphatic invasion in patients with node-negative mammary carcinoma. Cancer 2000;(69):1396—403.
6. Veronesi U., Cascinelli N., Mariani L. et al. Twenty-year follow-up of a ran- domized study comparing breast-con- serving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;(347):1217—32.
7. Gump F.E. Multicentricity in early breast cancer. Semin Surg Oncol 2001;177:330—7.
8. Погодина Е.М. Автореф. дис. ... канд. мед. наук. М., 2001.
9. Ravdin P., Olivotto I.A., Speers C. et al. Should estrogen receptor (ER) negativity alone be an indication for chemotherapy in T1N0 breast cancer? Proc ASCO 2003;22:abstr 55.
10. Kaptain S., Tan L.K., Chen B. Her-2/neu and breast cancer. Diagn Mol Pathol 2001;10(3):139—52.
11. Krauss D.J., Kestin L.L., Mitchell C. et al. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 2004;60(3):731—40.
12. Fredriksson I., Liljegren G., Arnesson L. et al. Local recurrence in the breast after conservative surgery-a study of prognosis and prognostic factors in 391 women. Eur J Cancer 2002;38(14):1860.
13. Vicini F., Harris J. New/alternative treatment approaches in local management of patients with early breast cancer. ASCO educational book, 2002. p. 296—303.
14. Elkhuizen P.H., Hermans J., Leer J.W. et al. Isolated late local recurrences with high mitotic count and early local recur- rences following breast-conserving thera- py are associated with increased risk on distant metastasis. Int J Radiat Oncol Biol Phys 2001;50(2):387—96.
15. Голдобенко Г.В., Михина З.П., Магилия Я., Курдюкова Л.Н. К проблеме органосохранного лечения больных раком молочной железы ранних стадий. В сб.: Высокие технологии в онкологии: Материалы V Всерос. съезда онкологов. Казань, 2000. Т. 3. с. 22—4.
16. Rajan R., Joseph L., Mailhot V. et al. Risk of local recurrence with delays in adjuvant radiotherapy for women with stage I or II breast cancer: an historical cohort study. Program and abstracts of the American Society of Clinical Oncology 36th Annual Meeting; May 20—23, 2000; New Orleans, Louisiana. Abstr 306.
17. Ficher B., Dignam J. Five versus more than five years of tamoxifen therapy for cancer patients with negative lymph nodes. J Natl Cancer Inst 1996;88:1529—42.
18. Van Tienhoven G., Voogd A.C., Peterse J.L. et al., Prognosis after treat- ment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999;35(1):32—8.
19. Bartelink H., Horiot J.C., Poortmans P.M. et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with nor without additional radiation. N Engl J Med 2001;345(19):1378—87.
20. Pergolizz S., Maisano R., Toskano G. Long-term survival in supraclavicular lymph node metastasis breast cancer as only site of disseminated disease. Pr Of Ascov 1999;474:18.
21. Cowen D., Jaeguemier J. Local and distant recurrence after conservative management of low risk breast cancer. Int J Radiat Oncol Phys 1998;41:801—7.
Review
For citations:
Molodikova N.R., Nechushkin M.I., Uimanov V.A., Trigolosov A.V., Chernykh M.V., Bekuzarova N.V. PREDICTORS OF A LOCAL RECURRENCE AFTER ORGAN-PRESERVING TREATMENT FOR EARLY BREAST CANCER: STATE-OF-THE-ART. Tumors of female reproductive system. 2009;(1-2):16-20. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-1-2-16-20
Views:
572
Email this article 